Pain medicine

Integrating machine learning and pathway modelling to explore factors associated with chronic post-surgical pain and quality of life: a secondary observational analysis of the ENIGMA-II trial

BJA OpenPublished Secondary analysis of the ENIGMA-II randomised trial

Authors' conclusion

A GLASSO-PLS-SEM workflow provided an exploratory approach to identifying key features and mapping hypothesised multivariable associations in CPSP-related outcomes.

Study context

Population
Participants of the ENIGMA-II chronic post-surgical pain (CPSP) substudy with 12-month postoperative assessmentENIGMA-II CPSP substudy
Participants
2,999 participants
Primary endpoint
Chronic post-surgical pain (CPSP) and related outcomes (EQ-5D, pain severity, pain interference)
Follow-up
12 months
Methodological detailssecondary observational analysis, exploratory, grouped lasso (GLASSO) feature selection, partial least squares structural equation modelling (PLS-SEM)
  • Secondary observational analysis
  • Exploratory
  • Grouped lasso (GLASSO) feature selection
  • Partial least squares structural equation modelling (PLS-SEM)

Primary result

As reported in the abstract

Factors associated with CPSP and related outcomes
GLASSO CPSP AUC
0.69 (95% CI 0.64-0.74)
GLASSO EQ-5D R2
0.34
GLASSO pain severity R2
0.29
GLASSO pain interference R2
0.24
PLS-SEM CPSP: presurgical pain (strongest association), B
0.348
PLS-SEM CPSP: demographics, B
0.169
PLS-SEM CPSP: surgical aspects, B
0.091
PLS-SEM CPSP: lifestyle patterns (small inverse association), B
−0.051
PLS-SEM EQ-5D: lifestyle (negative association), B
−0.248
PLS-SEM EQ-5D: NSAID-related treatment patterns, B
0.079

Original publication

Integrating machine learning and pathway modelling to explore factors associated with chronic post-surgical pain and quality of life: a secondary observational analysis of the ENIGMA-II trial. BJA Open. Published 17 June 2026. doi:10.1016/j.bjao.2026.100570

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.